Does the C34T Mutation in AMPD1 Alter Exercise Capacity in the Elderly?

Abstract

Ageing does affect functional capacity through several changes at the peripheral muscle level that impair the muscles capacity to produce energy and generate force. The skeletal muscle-specific isoform of AMP deaminase (AMPD) plays an important regulatory role in muscle metabolism and in determining energy charge. Since nearly 20 % of the general Caucasian population is heterozygous (CT) for the most common C34T mutation of the gene (AMPD1) encoding for this enzyme, it would be worthwhile to study if such a condition further increases the effects of ageing. Twenty-one women (61 - 80 yrs) served as subjects, and depending on the results of previous genotyping, were assigned to a group with the C34T mutation (heterozygous; n = 4; mean ± SEM age: 71 ± 1 yrs) or with no mutation (n = 17; 68 ± 1 yrs). Several indices of maximal (peak oxygen uptake [V·O_2peak], peak power output) and submaximal endurance performance (ventilatory threshold, mechanical efficiency) and functional tests (one-mile walk test and a specific test of lower-body functional performance [sit-stand test]) were compared between the two groups. No significant differences were found in exercise capacity between both groups, e. g. V·O_2peak of 19.1 ± 1.0 vs. 20.1 ± 1.9 ml · kg^-1 · min^-1, V·O₂ at the VT of 11.9 ± 0.6 vs. 12.9 ± 1.0 ml · kg^-1 · min^-1, or time to complete the one-mile walk test (951 ± 18 s vs. 962 ± 61 s) and sit-stand test (9.9 ± 0.2 vs. 9.2 ± 0.2) (no mutation vs. C34T mutation, respectively). Although more research is necessary, it seems that the C34T mutation of the AMPD1, at least in heterozygous individuals, does not affect functional capacity in the elderly.

Key words

AMP deaminase - mutation - allele - ageing - functional capacity

References

• 1 American College of Sports Medicine Position Stand . Exercise and physical activity for older adults.  Med Sci Sports Exerc. 1998;  30 992-1008
• 2 Beltran B C, Cuadrado L M, Martín A, Carvajal A, Moreiras O. Activities of daily living in the Spanish elderly. Association with mortality.  J Nutr Health Aging. 2001;  5 259-260
• 3 Blair S N, Kampert J B, Kohl 3rd H W. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women.  JAMA. 1996;  276 205-210
• 4 Calbet J AL, Jensen-Urstad M, van Hall G. et al . Maximal vascular conductance during whole body upright exercise in humans.  J Physiol. 2004;  558 319-331
• 5 Cartee G D. Aging skeletal muscle: response to exercise.  Exerc Sport Sci Rev. 1994;  22 91-120
• 6 Chavarren J, Calbet J AL. Cycling efficiency and pedalling frequency in road cyclists.  Eur J Appl Physiol. 1999;  80 555-563
• 7 Cottrell D A, Turnbull D M. Mitochondria and ageing.  Curr Opin Clin Nutr Metab Care. 2000;  3 473-478
• 8 De Ruiter C J, May A M, van Engelen B G, Wevers R A, Steenbergen-Spanjers G C, de Haan A. Muscle function during repetitive moderate-intensity muscle contractions in myoadenylate deaminase-deficient Dutch subjects.  Clin Sci (Lond). 2002;  102 531-539
• 9 Doherty T J, Vandervoort A A, Brown W F. Effects of ageing on the motor unit: a brief review.  Can J Appl Physiol. 1993;  18 331-358
• 10 Doherty T J, Vandervoort A A, Taylor A W, Brown W F. Effects of motor unit losses on strength in older men and women.  J Appl Physiol. 1993;  74 868-874
• 11 Durnin J V, Womersley J. Body fat assessed from total body density and its estimation from skinfold: measurements on 481 men and women aged from 16 to 72 years.  Br J Nutr. 1974;  32 77-97
• 12 Engel W K. Selective and nonselective susceptibility of muscle fiber types: A new approach to human neuromuscular diseases.  Arch Neurol. 1970;  22 97-117
• 13 Esbjornsson-Liljedahl M, Jansson E. Sex difference in plasma ammonia but not in muscle inosine monophosphate accumulation following sprint exercise in humans.  Eur J Appl Physiol. 1999;  79 404-408
• 14 Essen-Gustavsson B, Borges O. Histochemical and metabolic characteristics of human skeletal muscle in relation to age.  Acta Physiol Scand. 1986;  126 107-114
• 15 Fishbein W N, Armbrustmacher V W, Griffin J L. Myoadenylate deaminase deficiency: a new disease of muscle.  Science. 1978;  200 545-548
• 16 Fishbein W N, Foellmer J W, Davis J I. Medical implications of the lactate and ammonia relationship in anaerobic exercise.  Int J Sports Med. 1990;  11 91-100
• 17 Fisher N M, Pendergast D R, Calkins E C. Maximal isometric torque of knee extension as a function of muscle length in subjects of advancing age.  Arch Phys Med Rehabil. 1990;  71 729-734
• 18 Gallagher D, Visser M, De Meersman R E. et al . Appendicular skeletal muscle mass: effects of age, gender, and ethnicity.  J Appl Physiol. 1997;  83 229-239
• 19 Gotshalk L A, Volek J S, Staron R S, Denegar C R, Hagerman F C, Kraemer W J. Creatine supplementation improves muscular performance in older men.  Med Sci Sports Exerc. 2002;  34 537-543
• 20 Grabiner M D, Enoka R A. Changes in movement capabilities with aging.  Exerc Sport Sci Rev. 1995;  23 65-104
• 21 Gross M. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency.  J Inherit Metab Dis. 1997;  20 186-192
• 22 Guralnik J M, Simonsick E M, Ferrucci L, Glynn R J, Berkman L F, Blazer D G, Scherr P A, Wallace R B. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.  J Geront. 1994;  49 85-94
• 23 Heath G, Hagberg J, Ehsani A, Holloszy J. A physiological comparison of young and older endurance athletes.  J Appl Physiol. 1981;  51 634-640
• 24 Janssen I, Heymsfield S B, Wang Z M, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18 - 88 yr.  J Appl Physiol. 2000;  89 81-88
• 25 Jansson E, Dudley G A, Norman B, Tesch P A. ATP and IMP in single human muscle fibres after high intensity exercise.  Clin Physiol. 1987;  7 337-345
• 26 Kuipers H, Verstappen F T, Keizer H A, Geurten P, van Kranenburg G. Variability of aerobic performance in the laboratory and its physiologic correlates.  Int J Sports Med. 1985;  6 197-201
• 27 Kushiro W, Yokoyama T, Date C, Yoshiike N, Tanaka H. Association of activities of daily living and indices of mental status with subsequent 20-year all-cause mortality in an elderly Japanese population.  Nurs Health Sci. 2002;  4 5
• 28 Lanza I R, Towse T F, Caldwell G E, Wigmore D B, Kent-Braun J A. Effects of age on human muscle torque, velocity and power in two muscle groups.  J Appl Physiol. 2003;  95 2361-2369
• 29 Lexell J, Taylor C, Sjöström M. What is the cause of the ageing atrophy? Total number, size, and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men.  J Neurol Sci. 1988;  84 275-294
• 30 Lowenstein J M. Ammonia production in muscle and other tissues: the purine nucleotide cycle.  Physiol Rev. 1972;  52 382-414
• 31 Lusk G. Animal calorimetry: analysis of the oxidation of mixtures of carbohydrate and fat: a correction.  J Biol Chem. 1924;  59 41-42
• 32 McCully K, Posner J. Measuring exercise-induced adaptations and injury with magnetic resonance spectroscopy.  Int J Sports Med. 1992;  3 147-149
• 33 Morisaki T, Gross M, Morisaki H, Pongratz D, Zöllinger N, Holmes E W. Molecular basis of AMP deaminase deficiency in skeletal muscle.  Proc Natl Acad Sci USA. 1992;  89 6457-6461
• 34 Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood J E. Exercise capacity and mortality among men referred for exercise testing.  N Engl J Med. 2002;  4 793-801
• 35 Nichols J F, Patterson P, Early T. A validation of a physical activity monitor for young and older adults.  Can J Sport Sci. 1992;  17 299-303
• 36 Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2 % of healthy population.  Muscle Nerve. 1995;  18 239-241
• 37 Norman B, Sabina R L, Jansson E. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects.  J Appl Physiol. 2001;  91 258-264
• 38 Nybo L, Dalsgaard M K, Steensberg A, Moller K, Secher N H. Cerebral ammonia uptake and accumulation during prolonged exercise in humans.  J Physiol. 2005;  563 285-290
• 39 Nybo L, Secher N H. Cerebral perturbations provoked by prolonged exercise.  Progr Neurobiol. 2004;  72 223-261
• 40 Richardson R S, Grassi B, Gavin T P. et al . Evidence of O₂ supply-dependent V·O_2max in the exercise-trained human quadriceps.  J Appl Physiol. 1999;  86 1048-1053
• 41 Rico-Sanz J, Rankinen T, Joanisse D R, Leon A S, Skinner J S, Wilmore J H, Rao D C, Bouchard C. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family study.  Physiol Genomics. 2003;  14 161-166
• 42 Rubio J C, Martín M A, Del Hoyo P, Bautista J, Campos Y, Segura D, Navarro C, Ricoy J R, Cabello A, Arenas J. Molecular analysis of Spanish patients with AMP deaminase deficiency.  Muscle Nerve. 2000;  23 1175-1178
• 43 Sabina R L, Morisaki T, Clarke P, Eddy R, Shows T B, Morton C C, Holmes E W. Characterization of the human and rat myoadenylate deaminase genes.  J Biol Chem. 1990;  265 9423-9433
• 44 Sabina R L, Swain J L, Olanow C W, Bradley W G, Fishbein W N, DiMauro S, Holmes E W. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.  J Clin Invest. 1984;  73 720-730
• 45 Saltin B. Hemodynamic adaptations to exercise.  Am J Cardiol. 1985;  55 42-47
• 46 Sant'Ana Pereira J A, Sargeant A J, Rademaker A C, de Haan A, van Mechelen W. Myosin heavy chain isoform expression and high energy phosphate content in human muscle fibres at rest and post-exercise.  J Physiol. 1996;  496 583-588
• 47 Sinkeler S P, Binkhorst R A, Joosten E M, Wevers R A, Coerwinkei M M, Oei T L. AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischaemic isometric exercise.  Clin Sci (Lond). 1987;  72 475-482
• 48 Tanaka H, Seals D R. Invited Review: Dynamic exercise performance in Masters athletes: insight into the effects of primary human aging on physiological functional capacity.  J Appl Physiol. 2003;  95 2152-2162
• 49 Tarnopolski M A. Potential benefits of creatine monohydrate supplementation in the elderly.  Curr Opin Clin Nutr Metab Care. 2000;  3 497-502
• 50 Tarnopolsky M A, Parise G, Gibala M J, Graham T E, Rush J W. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.  J Physiol. 2001;  533 881-889
• 51 Thelen D G, Schultz A B, Alexander N B, Ashton-Miller J A. Effects of age on rapid ankle torque development.  J Geront A Biol Sci Med Sci. 1996;  51 226-232
• 52 Tsujino S, Shanske S, Carroll J E, Sabina R L, DiMauro S. Double trouble: combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both loci.  Neuromuscul Disord. 1995;  5 263-266
• 53 Verzijl H T, van Engelen B G, Luyten J A, Steenbergen G C, van den Heuvel L P, ter Laak H J, Padberg G W, Webers R A. Genetic characteristics of myoadenylate deaminase deficiency.  Ann Neurol. 1998;  44 140-143
• 54 von Strauss E, Aguero-Torres H, Kareholt I, Winblad B, Fratiglioni L. Women are more disabled in basic activities of daily living than men only in very advanced ages: a study on disability, morbidity, and mortality from the Kungsholmen Project.  J Clin Epidemiol. 2003;  56 669-677
• 55 Wasserman K, McIlroy M B. Detecting the threshold for anaerobic metabolism in cardiac patients during exercise.  Am J Cardiol. 1964;  14 844-852
• 56 Wong T C, Webster J G, Montoye H J, Washburn R. Portable accelerometer device for measuring human energy expenditure.  IEEE Trans Biomed Eng. 1981;  6 467-471